Department of Biological and Biomedical Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, United Kingdom.
Oral Sciences Research Group, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
mSphere. 2019 Jul 31;4(4):e00458-19. doi: 10.1128/mSphere.00458-19.
The enigmatic yeast has emerged over the last decade and rapidly penetrated our consciousness. The global threat from this multidrug-resistant yeast has generated a call to arms from within the medical mycology community. Over the past decade, our understanding of how this yeast has spread globally, its clinical importance, and how it tolerates and resists antifungal agents has expanded. This review highlights the clinical importance of antifungal resistance in and explores our current understanding of the mechanisms associated with azole, polyene, and echinocandin resistance. We also discuss the impact of phenotypic tolerance, with particular emphasis on biofilm-mediated resistance, and present new pipelines of antifungal drugs that promise new hope in the management of infection.
在过去的十年中,神秘的酵母已经出现,并迅速渗透到我们的意识中。这种具有多种耐药性的酵母对全球构成的威胁,已经引起了医学真菌学界的警觉。在过去的十年中,我们对这种酵母如何在全球范围内传播、其临床重要性以及它如何耐受和抵抗抗真菌药物的理解已经扩展。这篇综述强调了抗真菌耐药性在酵母中的临床重要性,并探讨了我们目前对抗唑类、多烯类和棘白菌素类耐药相关机制的理解。我们还讨论了表型耐受性的影响,特别强调了生物膜介导的耐药性,并介绍了有望在酵母感染管理方面带来新希望的新型抗真菌药物。